-
ACLA Submits Comments on CMS Transitional Coverage For Emerging Technologies Notice
-
ACLA Submits Comments on CMS Pre-Exposure Prophylaxis (PrEP) Proposed NCD
-
ACLA Submits Comments on the CDC’s NCVHS ICD-11 RFI
-
ACLA Submits Comments on Palmetto Special Stains/IHC Proposed LCD
-
Letter to ONDCP on NCCI Edits for Drug Testing
-
ACLA Submits Comments on Senate HELP Committee RFI on Reauthorization of the Pandemic All-Hazards Preparedness Act (PAHPA)
-
Letter from Leading Patient Advocacy Organizations on Passing the Saving Access to Laboratory Services Act
-
Routine Health Checkups – Including Recommended Laboratory Tests – Improve and Save Men’s Lives
June is Men’s Health Month, an opportunity to focus on the many ways that recommended clinical laboratory testing is essential in assessing, addressing and managing ... Read More -
Letter from Leading Provider Organizations on Passing the Saving Access to Laboratory Services Act
-
ACLA and 33 Provider Organizations Urge Congress to Protect Americans’ Access to Essential Laboratory Tests
Washington, D.C. – The American Clinical Laboratory Association has joined with more than 30 health care provider organizations to urge House and Senate leadership to protect ... Read More
